Skip to main content
. 2022 Apr 7;40(4):798–809. doi: 10.1007/s10637-022-01227-5

Fig. 1.

Fig. 1

Flow Diagram of New Targeted Multi-Indication Cancer Drugs Included in the Analysis, 2009–2019 FDA: US Food and Drug Administration, EMA: European Medicines Agency, HC: Health Canada, TGA: Therapeutics Goods Administration